NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Pacific Biosciences (NQ: PACB)
5.870 USD  -0.030 (-0.51%)
Official Closing Price  /  Updated: 4:31 PM EDT, Jul 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 981,745
Open 5.880
Bid (Size) 5.860 (129)
Ask (Size) 5.870 (147)
Prev. Close 5.900
Today's Range 5.840 - 5.900
52wk Range 3.330 - 7.840
Shares Outstanding 131,876,642
Dividend Yield N/A
Performance
YTD
-20.68%
-20.68%
1 Month
-12.13%
-12.13%
3 Month
-19.81%
-19.81%
6 Month
-17.56%
-17.56%
1 Year
+59.51%
+59.51%
Top News
More News
Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants
Identification of pathogenic structural variants with SMRT Sequencing improves solve rate for rare and Mendelian diseases Read More
from GlobeNewswire News Releases
Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results
Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached. Read More
from GlobeNewswire News Releases
More News
Read More
Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output
from GlobeNewswire News Releases
Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates
from GlobeNewswire News Releases
Notable Monday Option Activity: X, MGLN, PACB
category Stocks
from Market News Video
Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference
from GlobeNewswire News Releases
UK's CMA refers Illumina-Pacific Biosciences deal for in-depth investigation
category companyNews
from Reuters: Company News
Possible Trend Reversal, Pacific Bioscien Down on Heavy Volume (PACB)
from Comtex SmarTrend® News Briefs
UPDATE 1-UK's CMA says Illumina-Pacific Biosciences deal could hurt competition
category companyNews
from Reuters: Company News
Why Illumina Stock Jumped 20% in June
category PACB , CF , Market News , and 1 more.
from Motley Fool
UK's CMA says Illumina-Pacific Biosciences deal could hurt competition
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.